Reflect Scientific, Inc. (RSCF)
0.0454
-0.01
(-12.36%)
USD |
OTCM |
Aug 25, 16:00
Reflect Scientific Shareholders Equity (Quarterly) : 2.434M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.434M |
| March 31, 2026 | 2.341M |
| December 31, 2025 | 2.271M |
| September 30, 2025 | 2.153M |
| June 30, 2025 | 2.112M |
| March 31, 2025 | 2.118M |
| December 31, 2024 | 2.062M |
| September 30, 2024 | 2.080M |
| June 30, 2024 | 1.970M |
| March 31, 2024 | 1.861M |
| December 31, 2023 | 1.893M |
| September 30, 2023 | 2.075M |
| June 30, 2023 | 1.981M |
| March 31, 2023 | 2.156M |
| December 31, 2022 | 2.297M |
| September 30, 2022 | 2.351M |
| June 30, 2022 | 2.478M |
| March 31, 2022 | 2.399M |
| December 31, 2021 | 2.180M |
| September 30, 2021 | 1.792M |
| June 30, 2021 | 1.632M |
| March 31, 2021 | 1.461M |
| December 31, 2020 | 1.213M |
| September 30, 2020 | 0.764M |
| June 30, 2020 | 0.6439M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6502M |
| December 31, 2019 | 0.553M |
| September 30, 2019 | 0.4955M |
| June 30, 2019 | 0.494M |
| March 31, 2019 | 0.5122M |
| December 31, 2018 | 0.5177M |
| September 30, 2018 | 0.5018M |
| June 30, 2018 | 0.5444M |
| March 31, 2018 | 0.5541M |
| December 31, 2017 | 0.4554M |
| September 30, 2017 | 0.6413M |
| June 30, 2017 | 0.5822M |
| March 31, 2017 | 0.5691M |
| December 31, 2016 | 0.5715M |
| September 30, 2016 | 0.6225M |
| June 30, 2016 | 0.6724M |
| March 31, 2016 | 0.5906M |
| December 31, 2015 | 0.5547M |
| September 30, 2015 | 0.634M |
| June 30, 2015 | 0.6802M |
| March 31, 2015 | -0.5978M |
| December 31, 2014 | -0.5665M |
| September 30, 2014 | -0.5569M |
| June 30, 2014 | -0.4926M |
| March 31, 2014 | -0.4733M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 2.990B |
| Agilent Technologies, Inc. | 7.122B |
| Anika Therapeutics, Inc. | 137.28M |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Bruker Corp. | 2.381B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.646M |
| Total Liabilities (Quarterly) | 0.2119M |
| Debt to Equity Ratio | 0.019 |
| Current Ratio | 12.01 |
| Net Debt Paydown Yield | 0.67% |